Skip to main content
. 2017 Sep 25;53(3):178–186. doi: 10.4068/cmj.2017.53.3.178

TABLE 2. Developed therapeutic agents against RON (Recepteur D'Origine Nantais) in Gastric cancer.

graphic file with name cmj-53-178-i002.jpg

mAb: Monoclonal Antibody, TKI: Tyrosine kinase inhibitor, miR: Micro RNA, VEGFR: Vascular Endothelial Growth Factor Receptors, TIE: Tunica internal endothelial cell kinase, TRKA: Tropomyosin receptor kinase A, HSP: Heatshock protein.